Stay updated on Metformin in Longevity Study (MILES) Clinical Trial
Sign up to get notified when there's something new on the Metformin in Longevity Study (MILES) Clinical Trial page.

Latest updates to the Metformin in Longevity Study (MILES) Clinical Trial page
- Check4 days agoChange DetectedThe Metformin in Longevity Study record is displayed, including its study design, eligibility criteria, interventions and outcome measures, Bronx location, investigators, and record history.SummaryDifference41%

- Check11 days agoChange DetectedThe footer’s site revision label changes from v3.7.2 to v3.8.0. The page otherwise continues to show a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check18 days agoChange DetectedA banner announces an NIH-wide transition from the term “artificial intelligence” to “super intelligence.” The study page itself continues to show a 403 error.SummaryDifference1%

- Check25 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2; the page continues to display a 403 error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe site footer’s revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, indicating the study record is currently inaccessible.SummaryDifference17%

Stay in the know with updates to Metformin in Longevity Study (MILES) Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Metformin in Longevity Study (MILES) Clinical Trial page.